Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
NCT ID: NCT03290300
Last Updated: 2024-02-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2017-10-30
2022-07-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Nasal Airway Obstruction Using the Aerin Medical Device
NCT02914236
Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction
NCT03156270
Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device
NCT04684875
Evaluate the Effectiveness of the Vivaer ARC Stylus for Nasal Breathing
NCT04717791
A Study of RhinAer Stylus for Treating Chronic Rhinitis
NCT06599736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Long-Term Study Subjects
This cohort will consist of all subjects who were treated with the Vivaer Stylus in the 50-subject TP258 interventional study, who consent to continue to provide quality of life data.
Vivaer Stylus
Previous nasal obstruction treatment with the Aerin Medical Vivaer Stylus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vivaer Stylus
Previous nasal obstruction treatment with the Aerin Medical Vivaer Stylus
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aerin Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Wolf, MD
Role: STUDY_DIRECTOR
Aerin Medical
Ofer Jacobowitz, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
ENT and Allergy Associates, Middletown, NY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central California Clinical Research
Fresno, California, United States
Colorado ENT and Allergy
Colorado Springs, Colorado, United States
ENT and Allergy Associates, LLP
Oradell, New Jersey, United States
ENT and Allergy Associates, LLP
Bayside, New York, United States
ENT and Allergy Associates, LLP
Middletown, New York, United States
ENT and Allergy Associates, LLP
New Hyde Park, New York, United States
Piedmont Ear, Nose and Throat Associates
Winston-Salem, North Carolina, United States
Ear, Nose and Throat Associates of Texas
McKinney, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TP465
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.